Clinical Trials Logo

Filter by:
NCT ID: NCT02468323 Completed - PONV Clinical Trials

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia

PONV
Start date: October 2015
Phase: Phase 4
Study type: Interventional

This study aims to compare the quality of perioperative antiemesis of palonosetron and ondansetron in patients undergoing cesarean section

NCT ID: NCT02468219 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis Submitted to Valvar Correction

CARE-AS-MOTION
Start date: August 2020
Phase: N/A
Study type: Interventional

This study will be evaluate the autonomic, endothelial and hemodynamic functions, inspiratory muscle strength, peripheral tissue oxygenation, peripheral and respiratory muscle architecture, and inflammatory profile of severe AS patients submitted undergoing to valve replacement (sAVR) or transcatheter aortic valve implantation (TAVI), and their influence on the pathophysiological mechanisms involved in cardiovascular rehabilitation.

NCT ID: NCT02467972 Completed - Diabetes Clinical Trials

Functional Ingredients: Effect in Gastrointestinal System

Start date: April 2012
Phase: N/A
Study type: Interventional

The addition of fructans or unripe banana flour to frozen meals can change the hormonal parameters related to hunger and satiety, improve the bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR). The inulin no can change bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR)

NCT ID: NCT02467907 Completed - Cervical Cancer Clinical Trials

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer

Start date: July 28, 2015
Phase: Phase 2
Study type: Interventional

This study is to assess safety as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula in participants treated with bevacizumab 15 milligrams per kilogram (mg/kg) in combination with paclitaxel and carboplatin, all repeated every 3 weeks, for recurrent, persistent or metastatic cervical cancer. In addition, this study will include evaluation of the overall safety profile of bevacizumab in combination with paclitaxel and carboplatin in this setting, assessment of GI perforation/fistula, GI-vaginal fistula and GU fistula events over time, and evaluation of efficacy.

NCT ID: NCT02467751 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Women With Polycystic Ovary Syndrome (PCOS)

PCOS
Start date: January 2014
Phase: N/A
Study type: Observational

Metabolic profile in women of different body composition with polycystic ovary syndrome.

NCT ID: NCT02467686 Recruiting - Sexuality Clinical Trials

Breast Cancer, Sexuality and Black Cohosh

Cimicifuga
Start date: January 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the Cimicifuga racemosa effects on the sexuality of women with Breast cancer using tamoxifen or aromatase inhibitor through questionnaires.

NCT ID: NCT02467673 Completed - Menopausal Syndrome Clinical Trials

Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy

Nanoparticle
Start date: January 2012
Phase: Phase 2
Study type: Interventional

The study aims to asses the effects of micronized (MIC) and nanoparticulate (NANO) transdermal hormone therapy (THT) on blood pressure, ultra-sensitive C-reactive protein (CRP), and cardiovascular risk factors in postmenopausal women.

NCT ID: NCT02466542 Completed - Postoperative Pain Clinical Trials

Analgesic Effect of Intraoperative Esmolol in Mastectomies

Esmobreast
Start date: June 2015
Phase: Phase 4
Study type: Interventional

This study aims to compare the quality of perioperative analgesia of esmolol in patients undergoing mastectomy.

NCT ID: NCT02465502 Completed - Clinical trials for Colorectal Neoplasms

Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer

Start date: July 21, 2015
Phase: Phase 2
Study type: Interventional

To determine the efficacy (as measured by progression-free survival [PFS] rate at 8 weeks) of regorafenib in subjects with metastatic colorectal cancer (CRC) whose disease is refractory to standard therapies and who were never exposed to antiangiogenic therapy.

NCT ID: NCT02464540 Completed - Clinical trials for Optical Properties of Laminate Veneers

Optical Properties of Light Cured Luting Agent on Laminate Veneer

Start date: March 2015
Phase: N/A
Study type: Interventional

The aim of this randomized clinical trial is to evaluate the influence of luting agent, thickness and color of laminate veneers (LVs) and color of dental substrate on the optical properties of LVs.